The Sigma Healthcare Ltd (ASX: SIG) share price has seen its fair share of volatility in the last year, as the chart below shows. The owner of Chemist Warehouse, Amcal and Discount Drug Stores has delivered strong financial performance, even if the valuation hasn’t reflected that.

When a business reports solid earnings growth, it normally leads to strong shareholder returns. The FY26 result clearly demonstrated what the company is capable of.

Let’s review what the company achieved in the 2026 financial year, then consider what experts think of Sigma Healthcare’s share price.

FY26 earnings recap

In the 2026 financial year, revenue grew by 15.5% to $10.8 billion. The Australian segment grew revenue by 14.9% to $10.4 billion, while the international segment grew revenue by 33% to $421.4 million. Australian Chemist Warehouse like-for-like sales growth was 13.4%, while international like-for-like sales growth was 12.2%.

That’s an impressive level of growth considering how long the company has been growing.

It added 24 Chemist Warehouse branded stores to the Australian network to reach 561, while the international segment opened 20 stores offshore to reach 98.

Profit improved even faster than revenue. The company’s normalised operating profit (EBIT) grew 20.6% to $1.09 billion, with the EBIT margin improving to 10.1%. Within that, Australian EBIT rose 18.3% and international EBIT grew 91.3%. Normalised net profit increased by 22.3% to $732.3 million.

It also revealed that net debt reduced to $663 million, so the balance sheet health improved on a debt-to-normalised EBITDA ratio basis to 0.57x.

The merger between Sigma Healthcare and Chemist Warehouse continues to deliver significant integration synergies. The synergies delivered reached $32.6 million. The company said it’s on track to reach $100 million per year by FY29.

There were solid growth numbers all around. The company’s earnings look set to grow in FY27. In its outlook commentary, the company said Australian Chemist Warehouse branded store network continues to see double-digit like-for-like sales growth.

For the first half of FY27, it plans to onboard 13 Chemist Warehouse stores in the Australian network and another 19 international stores, including its entry into the UK market. It also plans to open 42 stores across Amcal and Discount Drug Stores in Australia during the first half of FY27.

Sigma Healthcare share price target

A price target is where analysts think the share price of a business will be in 12 months from the time of the investment call.

According to CMC Invest, there have been 11 analyst ratings on the business within the last three months. Nine of those ratings were a buy, and two were a hold. The average price target of those 11 analysts is $3.14, suggesting a possible rise of 10% over the next year.

The most optimistic price target is $3.58. This implies a possible rise of around 25% over the next year.

Overall, it seems like a compelling long-term opportunity, though it’s not the only ASX stock worth looking at.

The post How much could the Sigma Healthcare share price rise in the next year? appeared first on The Motley Fool Australia.

More reading

• ASX 200 utilities and healthcare shares win the week again
• Why these are my favourite ASX growth shares to buy and hold
• Here are the top 10 ASX 200 shares today
• UBS’ top nine ASX large-cap stock picks
• 3 ASX 200 shares I would buy and hold for 10 years

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Global X will pay its next round of distributions to ASX exchange-traded fund (ETF) investors today.

We have listed the distribution amounts, rounded to two decimal places, below.

If you elected to participate in Global X’s distribution reinvestment plan (DRP), you will receive your new units today.

The DRP allows investors to instruct Global X to automatically use their dividends to buy more units on their behalf.

The DRP prices for each Global X ETF are also listed below.

Global X ASX ETF distributions

ETF	Distribution	Franking	DRP price
Global X Australia 300 ETF (ASX: A300)	41.37 cents per unit	82%	50.7 cents per unit
Global X S&P/ASX 200 Covered Call Complex ETF (ASX: AYLD)	10.5 cents per unit	82%	10.18 cents per unit
Global X Australian Bank Credit ETF (ASX: BANK)	6.31 cents per unit	44%	9.79 cents per unit
Global X Australia ex Financial & Resources ETF (ASX: OZXX)	9.32 cents per unit	63%	9.79 cents per unit
Global X Nasdaq 100 Covered Call Complex ETF (ASX: QYLD)	8.86 cents per unit	0%	11.23 cents per unit
Global X Russell 2000 ETF (ASX: RSSL)	1.43 cents per unit	0%	9.55 cents per unit
Global X USD High Yield Bond (Currency Hedged) ETF (ASX: USHY)	12.42 cents per unit	0%	8.72 cents per unit
Global X USD Corporate Bond (Currency Hedged) ETF (ASX: USIG)	10.46 cents per unit	0%	8.48 cents per unit
Global X US Treasury Bond (Currency Hedged) ETF (ASX: USTB)	7.91 cents per unit	0%	8.48 cents per unit
Global X S&P 500 Covered Call Complex ETF (ASX: UYLD)	6.29 cents per unit	0%	10.62 cents per unit
Global X S&P/ASX 200 High Dividend ETF (ASX: ZYAU)	16.19 cents per unit	84%	9.93 cents per unit
Global X S&P 500 High Yield Low Volatility ETF (ASX: ZYUS)	12.55 cents per unit	0%	13.7 cents per unit

Curious about what other ETFs are paying?

Vanguard paid its latest round of dividends to ETF investors last Friday.

Vanguard manages some of the largest funds on the market.

They include Vanguard Australian Shares Index ETF (ASX: VAS) and Vanguard Australian Shares High Yield ETF (ASX: VHY).

See how much Vanguard investors received here.

Betashares also paid dividends last Friday.

See how much Betashares ETF investors received here.

BlackRock paid distributions to ETF investors on 9 October.

You can view the final amounts here.

The post ASX ETF investors will receive dividends today. Here is how much you'll get appeared first on The Motley Fool Australia.

More reading

• ASX ETF dividends: Global X reveals next payments

Motley Fool contributor Bronwyn Allen has positions in Vanguard Australian Shares High Yield ETF. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Vanguard Australian Shares High Yield ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares rose 1% last week and are down 2.5% over 12 months.

Here’s what Michael Gable from Fairmont Equities thinks of these 3 ASX 200 shares (courtesy The Bull). 

Santos Ltd (ASX: STO)

The Santos share price rose 3.88% to close at $9.11 last week.

Gable has a buy rating on this ASX 200 energy share. 

He said: 

Santos is a global energy company. We’ve been bullish on the outlook for oil and gas since 2025 due to a looming imbalance between supply and demand.

Investors have been underweight in the energy sector, but buying support is emerging for major oil and gas companies like Santos.

The shares have risen from $6.15 on January 2 to trade at $9.14 on October 15.

A major technical breakout in Santos shares was achieved this month, which is a positive sign and indicates potentially higher prices moving forward.

BHP Group Ltd (ASX: BHP)

The BHP share price fell 1.49% to finish at $60.03 last Friday.

Gable has a hold rating on this ASX 200 mining share. 

He commented: 

BHP is one of the world’s biggest miners and most of its earnings is now generated from copper.

In our view, we remain in the early stages of a commodities boom. The copper price continues to trend higher due to supply constraints and increasing demand.

The company posted an attributable profit of $US9.8 billion in full year 2026, up 9 per cent on the prior corresponding period.

It was recently trading on a fully franked dividend yield of almost 4 per cent, which is attractive for Australian shareholders in light of the Federal Government’s changes to capital gains tax rules.

Telstra Group Ltd (ASX: TLS)

The Telstra share price edged 0.63% lower to $4.74 last week.

Gable has a sell rating on this ASX 200 telco share. 

Gable explained: 

Stock in this telecommunications giant enjoyed a good run in the two years up to May 2026, but has fallen back and formed a negative reversal signal on the share price chart.

In an environment of higher interest rates, Telstra’s dividend loses appeal when compared to cash in the bank.

Telstra shares have fallen from $5.55 on May 19 to trade at $4.785 on October 15.

In our view, low growth prospects and possibly increasing competition from SpaceX‘s Starlink leaves the share price under pressure.

The post Buy, hold, sell: Santos, BHP, Telstra shares appeared first on The Motley Fool Australia.

More reading

• If I could only buy 5 ASX shares for retirement, these would make my shortlist
• Buy, hold, sell: BHP, DroneShield, and Lynas shares
• I look for 3 things in a retirement stock. These 5 shares have them all
• 9 ASX 200 shares experts are backing for growth amid market weakness
• How much do I need in my superannuation to generate a $108,000 annual passive income?

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Telstra Group. The Motley Fool Australia has recommended BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.